Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2015-01-09)Premium Content



2015-03-31@07:10:28 ET
Biogen/AbbVie's MS Drug Zinbryta Under Review in the EU (ZAX)

2015-03-31@06:58:49 ET
Testosterone Replacement Therapy (TRT) - Global Strategic Business Report 2015: Easy-to-use Formulations - A Major Boost to TRT Market (MTO)

2015-03-31@05:15:35 ET
Nephropathy Global Clinical Trials Review, H1, 2015 (MTO)

2015-03-31@04:42:53 ET
Renal Failure Global Clinical Trials Review, H1, 2015 (MTO)

2015-03-30@09:37:33 ET
8-K: AbbVie Inc. (EDK)

2015-03-27@07:00:01 ET
European Medicines Agency Validates Marketing Authorisation Application for ZINBRYTA(TM) (Daclizumab High-Yield Process) for Treatment of MS (BIZ)

2015-03-27@04:44:27 ET
AbbVie signs license agreement with C2N for Alzheimer's disease therapy (DTM)

2015-03-24@22:28:40 ET
US Patent Issued to AbbVie on March 24 for "Anti-infective agents and uses thereof" (Illinois, Wisconsin Inventors) (ABW)

2015-03-24@16:16:32 ET
AbbVie signs licensing agreement with C2N Diagnostics (DTF)

2015-03-24@09:31:00 ET
Critical Alerts For Canadian Solar, Intrexon, Intercept Pharmaceuticals, Amazon.com, Caesars Entertainment, AutoZone, Qlogic, Darden Restaurants, AbbVie and NTELOS Released By InvestorsObserver (PRN)

2015-03-23@11:13:31 ET
8-K: AbbVie Inc. (EDK)

2015-03-21@04:38:04 ET
Form 144: Filing to Sell 12314 Shares of AbbVie Inc (ABBV) (VKR)

2015-03-21@04:37:54 ET
Form 144: Filing to Sell 25000 Shares of AbbVie Inc (ABBV) (VKR)

2015-03-20@06:33:56 ET
AbbVie partners with C2N to develop anti-tau antibodies for Alzheimer's Disease (MTO)

2015-03-19@08:54:54 ET
AbbVie And C2N Enter Into A Worldwide License Agreement For Alzheimer's Disease Therapy (EUR)

2015-03-19@08:44:00 ET
AbbVie And C2N Enter Into A Worldwide License Agreement For Alzheimer's Disease Therapy (PRN)

2015-03-17@08:01:49 ET
AbbVie's Dermatology Leadership Showcased with HUMIRA(R) (adalimumab) Data at American Academy of Dermatology 2015 Annual Meeting (EUR)

2015-03-17@08:00:00 ET
(PRN)

2015-03-13@22:19:00 ET
AbbVie Inc.Corporate Event Announcement Notice (WSH)

2015-03-13@11:10:30 ET
Mantle Cell Lymphoma Therapeutics Pipeline Review 2015 - Featuring 39 Companies (MTO)